🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#MondayNightIBD Haley Mertens Katie Dunleavy Jalpa Devi Aimen Farooq Noor S. Syed, MD Mehak Bassi, MD Marcel Yibirin, MD, MPH Sanjeevani Tomar, MD Dheera Grover Samiksha Pandey, MD, MSc NEJM Adam Faye MD MS Adam C. Ehrlich, MD, MPH, FACG Brad Morganstern, MD Berkeley Limketkai Benjamin Clement, MD Ben Click Bharati Kochar 𝙱𝚎𝚗 𝙳𝚒𝚜𝚗𝚎𝚢 Bram Verstockt Dana Lukin MD, PhD Dr Dawn Beaulieu Michael J Rosen, MD, MSCI The Lancet Freddy Caldera, DO, PhD Jordan Axelrad, MD, MPH Meena Bewtra Harry Thomas Mohamad El Zein MD, MPH  د. محمد عبدالله شهاب Daniel J. Stein Joshua M. Steinberg, MD Eric Benchimol Neilanjan Nandi, MD, FACG, AGAF, FCCF, FACP Harry Sokol Edward Loftus Tauseef Ali MD, FACG AGAF FACP David Fudman, MD Frank I Scott, MD MSCE FB IBDologist… Fabio Teixeira Fabi An E. Puentes M. carlos rettally Sara Horst MD, MPH, FACG Amar S. Naik, MD Beatriz Gros Miguel Regueiro ignacio catalan Lumír Kunovský 11/ Gus in Crohns 📊Clinical Remission 🗓️Post-induction wk12: large delta for both bio-exposed & naive 🗓️wk52: 60% vs 17% w similar results bio-naive & exposed 🤔Similar response w higher/lower SC maintenance dose 🔦Endo response: delta (44) w higher SC dose > (37) w lower dose

Impact of Endoscopic Healing on Disease-Related Outcomes in Patients With Ulcerative Proctitis IBDJournal & CC360 Dana Lukin MD, PhD Robert Battat MD Laura C Sahyoun, MD academic.oup.com/ibdjournal/art…

Y-ECCO IBDJournal & CC360 Robert Battat MD Laura C Sahyoun, MD Very proud of Esther Liu, MD for her work on this project! Data suggest a possible benefit for #endoscopichealing on clinical outcomes in #proctitis. Treat to 🎯 in UP #TTT #IBD Weill Cornell Medicine IBD

🔎From RCT data➡️clinic ✅#IL23 in #UlcerativeColitis: The How, The When & The Why w Robert Battat MD 🎥Video convo Mon, 4/7 w Aline Charabaty, MD, FACG, AGAF & share your experience w us! 🗳️Pre🎥#IBDPolls 🆓#CME👉🏽bit.ly/IL23sVideo2CME Support by edu grant Eli Lilly and Company 📌Where are you in ur🩺

Bifidobacteria support optimal infant vaccine responses ⁦nature⁩ nature.com/articles/s4158…

🛠️The How ⏱️The When 📊The Why for IL23s in #UlcerativeColitis 🎥 Convo with Robert Battat MD & Aline Charabaty, MD, FACG, AGAF x.com/i/broadcasts/1…

🛠️The How ⏱️The When 📊The Why for IL23s in #UlcerativeColitis 🎥 Convo with Robert Battat MD & Aline Charabaty, MD, FACG, AGAF x.com/i/broadcasts/1…

💪Finishing our IL23s series strong 💪 #MondayNightIBD ~ IL23s in #UlcerativeColitis from RCT➡️Clinic🎥Convo w/ Robert Battat MD & Aline Charabaty, MD, FACG, AGAF Support by an edu grant from Eli Lilly and Company 🖱️Video🔗👇to watch/listen to the convo 🗳️Answer post #IBDPolls 🆓CME from

A test that shows a huge reduction in clinical remission rates in #crohn trial Aline Charabaty, MD, FACG, AGAF Beatriz Gros Shrinivas Bishu Y-ECCO academic.oup.com/ecco-jcc/advan…

We conclude our series on the 🆕MOA in #IBD 🧰 :Anti #IL23p19 w 🌟faculty Waqqas Afif, MD Shrinivas Bishu Robert Battat MD TY #MondayNightIBD🏘️ for sharing insights & expertise ✅Poll results on positioning IL23 in CD & UC bionaive/exposed ✅#IBDAlgo for practical tips👇🏽

What a pleasure hosting the one and only Dr. Charles Bernstein from Gastrointestinal Research, University of Manitoba at Pitt Division of GI, Hepatology & Nutrition Gut Club. The lecture was great but the conversation afterward was the highlight - a genuine, fun person

Aline Charabaty, MD, FACG, AGAF #MondayNightIBD Sang Hyoung Park Emad Mansoor Jan Král Rashid Lui 雷諾信 Javier A. Villafuerte Gálvez Gui Ramos MD Laura Raffals, MD Edward Loftus Manuel Braga Neto MD, PhD So, do we optimize IBD therapy to reduce flare risk? Or "unleash" the immune system (to fight the cancer) by scaling back on IBD therapy? Jordan Axelrad, MD, MPH Jean-Frederic Colombel KattahLab Shrinivas Bishu Ryan Ungaro MD MS Sung Wook Hwang MD

Open-access nature paper from the GIVES-21 consortium, co-led by Siew Ng and I, funded by Helmsley Charitable Trust, and supported by IOIBD, reveals the global evolution of IBD across epidemiologic stages. Co–first authors: Dr. LD & @LingWWindsor nature.com/articles/s4158…

Global evolution of inflammatory bowel disease across epidemiologic stages | ⁦nature⁩ ⁦⁦Gil Kaplan MD MPH⁩ nature.com/articles/s4158…

Global evolution of inflammatory bowel disease across epidemiologic stages | Nature #IBD ⁦nature⁩ ⁦Gil Kaplan MD MPH⁩ There are 4 epidemiological stages of #Crohns and #UC and North America is in 3rd stage nature.com/articles/s4158…

Over a decade since I collaborated with world-class epidemiologist Gil Kaplan MD MPH and his team, here is our long awaited paper out in nature reporting for the first time evolution of #ibd across 4 stages Helmsley Charitable Trust IOIBD CUHK Medicine GIVES-21 nature.com/articles/s4158…

Siew Ng nature Helmsley Charitable Trust IOIBD CUHK Medicine GIVES-21 Thank you so much. So excited to be in New York with you when the paper came out today.

Long term outcomes of biologic exposure in utero: Arushi Kohli presenting PIANO data showing no evidence of harm out to at least 4 years. UCSF Health Digestive Disease Week

Spatial mapping and geographic variation of inflammatory bowel disease in Canada: A population-based study pubmed.ncbi.nlm.nih.gov/40326445/